Spyre Therapeutics Inc (SYRE) Stock Price, Quote, News & History

SYRENASDAQ
$98.95
5.225.57%
At close: Jul 14, 5:00 PM EST
$100.51
1.561.57%
After Hours: 6:44 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-185.63M
Investing Cash Flow (TTM)
-86.83M
Financing Cash Flow (TTM)
321.15M
Free Cash Flow (TTM)
-185.63M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
48.69M

Analyst Trends and Forecast

3
Mar
9
Apr
2
May
3
Jun
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.55B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
15.80
Earnings Yield % (TTM)
-2.26%
Earnings Yield % (FWD)
-3.52%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.93

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$97.19M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$96.06
Close
$98.95
Volume / Avg.
2.78M / 1.48M
Day Range
$94.96 - $105.09
52 Wk Range
14.51 - 102.06
Market Cap
$8.67B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
65
Short Interest
16.94%
Days to Cover
5.56

About

Sector
Health Care
Industry
Biotechnology
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes exten...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Spyre Therapeutics (SYRE) stock?

A

You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Spyre Therapeutics (SYRE) competitors?

A

There are no as such competitors for Spyre Therapeutics.

Q

What is the forecast, or price target, for Spyre Therapeutics (SYRE) stock?

A

Spyre Therapeutics has a consensus price target of $90.07.

Q

What is the current price for Spyre Therapeutics (SYRE)?

A

The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $100.5077 last updated July 14, 2026 at 6:44 PM EDT.

Q

Does Spyre Therapeutics (SYRE) pay a dividend?

A

There are no upcoming dividends for Spyre Therapeutics.

Q

When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?

A

Spyre Therapeutics does not have any upcoming earnings scheduled.

Q

Is Spyre Therapeutics (SYRE) going to split?

A

There is no upcoming split for Spyre Therapeutics.

Q

What sector and industry does Spyre Therapeutics (SYRE) operate in?

A

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.